IMCD Group, a global distribution partner and formulator of specialty chemicals and ingredients, recently announced the expansion of its Pharmaceuticals Technical Centre in Jakarta, Indonesia. This facility will serve as the hub for pharmaceutical development and innovation across Southeast Asia, Australia, and New Zealand.
Avantor has opened its latest Innovation Center in Bridgewater, New Jersey, US, “to support the growing demands for monoclonal antibodies, cell and gene therapy and mRNA workflows.” The new center is now part of the company’s network of 13 global research and innovation centers.
Zofingen, Switzerland-based contract development and manufacturing organization (CDMO) Siegfried inaugurated its new global research and development (R&D) center for drug substances at its site in Evionnaz, Switzerland. The 4,500 m2 center houses chemical and analytical facilities, laboratories, and technologies such as flow chemistry, advanced distillation and process analytical technology, as well as new office space.
Ambiopharm, a US-based pharmaceutical services company specializing in peptide manufacturing, recently announced the groundbreaking of a 70,000-square-foot (6,504 m2) capacity expansion project at its Shanghai manufacturing site. This $28 million (€26.6 million) project reflects the company’s commitment to serving growing global demand and confidence in China’s vital role in the global pharmaceutical supply chain.
Anglo-Swedish drugmaker AstraZeneca plans to invest $3.5 billion in the US to expand the company’s research and manufacturing footprint by the end of 2026.
Dutch specialty chemicals producer Nouryon has completed the capacity expansion for organic peroxides at its manufacturing facility in Ningbo, China. The expansion doubled production capacity to 6,000 tons of organic peroxide products each, which are sold under the Perkadox 14 and Trigonox 101 brands.
Lonza, a global contract development and manufacturing organization (CDMO) for the pharmaceutical, biotech, and nutraceutical markets, announced today that it will invest in additional bioconjugation capabilities in Visp, Switzerland.
German specialty chemicals group Evonik broke ground on its plant expansion for specialty amines at its site Nanjing, China, on Nov. 8. Construction work is expected to be completed in 2026.
SABIC recently announced the official launch of its new US$170 (€157.7) million ultem resin manufacturing facility in Singapore, marking the company’s first advanced specialty chemical manufacturing facility in the region producing the high-performance thermoplastic, ultem resin.
Belgium-headquartered pharmaceutical contract development and manufacturing organization (CDMO) Ardena announced plans to expand its bioanalytical services in the Netherlands. As part of the investment, the company plans to establish a new bioanalytical laboratory at its Pivot Park facility in Oss, as well as additional capacity and new GLP capabilities at its bioanalytical center of excellence in Assen.
Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO), today announced the second phase of an expansion strategy at its Deeside, UK site to support antibody-drug conjugate (ADC) development, with a more than £10 million (€11.9 million) investment to increase GMP bioconjugation capacity.
British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.
Italian energy group Eni has finalized its transformation and relaunch plan for Versalis, its chemicals business. As part of the plan, Eni will invest about €2 billion to reduce emissions by approximately 1 million t of CO2, currently about 40% of Versalis' emissions in Italy.
In a move to further increase production efficiency and modernize the site, German contract development and manufacturing organization (CDMO) Rentschler Biopharma plans to construct a new buffer media station at its company headquarters in Laupheim. According to Rentschler, this is the largest single investment in the German site.
Dutch renewables specialist Avantium has officially opened its FDCA (furandicarboxylic acid) flagship plant in Delfzijl, the Netherlands. Plans for what was said to be the world's first commercial-scale production plant for FDCA were first announced in December 2021.
Today, Cambrex announced its stability storage business, Q1 Scientific, and opened a new cGMP facility in Durham, North Carolina, expanding its capacity for environmentally controlled stability storage services to North America's pharmaceutical, medical device, and life sciences industries.
US contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS), part of India-headquartered Piramal Pharma, plans to invest $80 million for the expansion of its Lexington, Kentucky, facility.
Eli Lilly and Company (Lilly) recently announced a $4.5 billion (€4.07 billion) investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development.
South Korean contract development and manufacturing organization (CDMO) SK Pharmteco announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment to construct a new facility in Sejong, South Korea.
A.P. Moller Holding, the mother company of shipping giant Maersk, has launched Vioneo, a manufacturer of fossil-free plastic resins and intends to establish its first production complex in Antwerp, Belgium. The plant, in which Vioneo plans to invest €1,5 billion, will benefit from the region’s expertise in the chemicals industry, strong export facilities and access to renewable energy, the company said.
Evonik recently announced the groundbreaking of a significant expansion at its Charleston site in South Carolina’s Berkeley County.
Lonza has completed its acquisition of the Genentech large-scale biologics manufacturing site in Vacaville, California, USA, from Roche for $1.2 billion. The deal was announced in March of this year.
Carbon Waters recently reached a major milestone with the installation of its first production unit at its facility in Pessac.
On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to Boehringer Ingelheim, the investment of around €60 million is further proof of the company's commitment to cancer research.
Lonza inaugurated its new facility at the Colmar, France site. The new Innovaform Accelerator will serve as a Center of Excellence for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.
Covestro will start the construction of a new Thermoplastic Polyurethanes (TPU) APAC Application Development (AD) Center in Guangzhou, China.
Nouryon recently announced it has commenced operations at its new Integrated Manufacturing Model site in Ribas do Rio Pardo, Mato Grosso do Sul, Brazil, which includes the production of hydrogen peroxide, sodium chlorate, and chlorine dioxide.
The chemical industry faces acute labor shortages because the talent pool is shrinking, but the industry remains heavily reliant on manual work. Therefore, realizing labor productivity potential will be decisive for business continuity and future growth.
CDMO Serán BioScience recently announced that it has completed an expansion to increase the number of process manufacturing suites at its facility in Bend, Oregon, from 6 to 14, adding approximately 130% more cGMP clinical manufacturing capacity.
Lonza recently announced that it has completed a planned expansion of the mid-scale microbial manufacturing facility at its Visp, Switzerland site. This multi-product facility was recently granted a GMP license, allowing cGMP manufacturing and release of biologics produced using microbial fermentation.
Abu Dhabi National Oil Company (ADNOC) has agreed to acquire a 35% equity stake in ExxonMobil’s proposed low-carbon hydrogen and ammonia production facility in Baytown, Texas, US.
Evonik has completed the expansion of its MetAmino (DL-methionine) production facilities in Singapore and the production on Jurong Island is again running at full capacity, after shutdowns in the fourth quarter of 2023 and the second quarter of 2024.
QatarEnergy has decided to build a new, world-scale urea production complex in Mesaieed Industrial City. The project comprises the construction of three ammonia production lines that will supply feedstock to four new urea production trains at the site.
BASF's Coatings division has inaugurated its new application and technical center in Jiangmen, China, which is located within the site of BASF Coatings (Guangdong) (BCG).
Chinese chemical group Wanhua has launched its 48,000-ton-per-year citral production facility in Yantai, China.
